[{"NetIncomeLoss_1_Q3_USD":-60833000.0,"Investments_0_Q3_USD":387949000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":41839000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":14682000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":92599781.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":92692515.0,"CommitmentsAndContingencies_0_Q3_USD":null,"InterestIncomeOther_3_Q3_USD":563000.0,"InterestIncomeOther_1_Q3_USD":157000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":20102000.0,"BusinessCombinationContingentConsiderationLiability_0_Q3_USD":50465000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":10000.0,"IncreaseDecreaseInCommodityContractAssetsAndLiabilities_3_Q3_USD":-3403000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-186766000.0,"Depreciation_3_Q3_USD":2891000.0,"PaymentsToAcquireInvestments_3_Q3_USD":653633000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":13000.0,"AssetsCurrent_0_Q3_USD":639259000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":9544443.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":9544443.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":900000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":123000000.0,"Liabilities_0_Q3_USD":100527000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":21545000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":228559000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-1503000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":13082000.0,"LettersOfCreditOutstandingAmount_0_Q3_USD":1700000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":559000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":157000.0,"AccountsReceivableNetCurrent_0_Q3_USD":804000.0,"Revenues_3_Q3_USD":2462000.0,"Revenues_1_Q3_USD":666000.0,"ContractWithCustomerAssetNet_0_Q3_USD":4251000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_3_Q3_USD":120743000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q3_USD":44974000.0,"CommonStockSharesIssued_0_Q3_shares":92800072.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":4078000.0,"RestrictedCash_0_Q3_USD":2578000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":2000000.0,"FairValueAdjustmentOfWarrants_1_Q3_USD":2000000.0,"FairValueOfAssetsAcquired_3_Q3_USD":662000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-296416000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-60833000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_3_Q3_USD":-54000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax_1_Q3_USD":74000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-296470000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-60759000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3_Q3_USD":2000000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":387949000.0,"Assets_0_Q3_USD":671615000.0,"OtherComprehensiveIncomeLossNetOfTax_3_Q3_USD":-54000.0,"OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax_1_Q3_USD":74000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-700644000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-217387000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-74276000.0,"CommonStockSharesOutstanding_0_Q3_shares":92800072.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_0_Q3_shares":9770520.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":23000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":12418000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-34699000.0,"LiabilitiesCurrent_0_Q3_USD":28517000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1371000.0,"AccountsPayableCurrent_0_Q3_USD":6316000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":17696000.0,"AreaOfLand_0_Q3_sqft":46631.0,"IncreaseDecreaseInOtherOperatingAssets_3_Q3_USD":-22000.0,"StockIssued1_3_Q3_USD":61948000.0,"AdditionalPaidInCapital_0_Q3_USD":1271630000.0,"FiniteLivedIntangibleAssetsNet_0_Q3_USD":2300000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":33000.0,"ProceedsFromSaleAndMaturityOfOtherInvestments_3_Q3_USD":494673000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":6239000.0,"NetIncomeLoss_3_Q3_USD":-296416000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":231137000.0,"IncreaseDecreaseInPrepaidExpense_3_Q3_USD":7147000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":387939000.0,"StockholdersEquity_0_Q3_USD":571088000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":74000.0,"ShareBasedCompensation_3_Q3_USD":38236000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":21239000.0,"VariableInterestEntityInitialConsolidationGainOrLoss_3_Q3_USD":-11855000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":4078000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"PaymentsToAcquireBusinessesNetOfCashAcquired_3_Q3_USD":25215000.0,"CommonStockSharesAuthorized_0_Q3_shares":150000000.0,"CommonStockValueOutstanding_0_Q3_USD":92000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":2462000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2591000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":666000.0,"OperatingIncomeLoss_1_Q3_USD":-60990000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":331000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":671615000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":38236000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":12418000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1768000.0,"OperatingExpenses_3_Q3_USD":299437000.0,"OperatingExpenses_1_Q3_USD":61656000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-3.2,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.66,"OperatingIncomeLoss_3_Q3_USD":-296975000.0,"LiabilitiesAssumed1_3_Q3_USD":2330000.0,"Ticker":"RLAY","CIK":"1812364","name":"RELAY THERAPEUTICS, INC.","OfficialName":"Relay Therapeutics Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"3171086334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]